Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Revolution Medicines Inc. Common Stock (RVMD) vs Ternium S.A. Ternium S.A. American Depositary Shares (each representing ten shares USD1.00 par value) (TX) Price & Performance

Revolution Medicines Inc. Common StockTrade
Ternium S.A. Ternium S.A. American Depositary Shares (each representing ten shares USD1.00 par value)Trade

Price performance (Past 24H)

Key statistics

Revolution Medicines Inc. Common Stock vs Ternium S.A. Ternium S.A. American Depositary Shares (each representing ten shares USD1.00 par value) — how do they compare? Revolution Medicines Inc. Common Stock trades at $193.15 (market cap $40.39B), while Ternium S.A. Ternium S.A. American Depositary Shares (each representing ten shares USD1.00 par value) trades at $58.55 (market cap $11.58B). The key difference: Revolution Medicines Inc. Common Stock is far larger — about 3.5× Ternium S.A. Ternium S.A. American Depositary Shares (each representing ten shares USD1.00 par value)'s market cap, and Ternium S.A. Ternium S.A. American Depositary Shares (each representing ten shares USD1.00 par value) pays a 3.73% dividend while Revolution Medicines Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Revolution Medicines Inc. Common Stock for 2 Days and Ternium S.A. Ternium S.A. American Depositary Shares (each representing ten shares USD1.00 par value) for 0 Days on average.

RVMDTX
Market Cap
$40.39B$11.58B
Volume
2,941,009456,367
Sector
HealthBasic Materials
52-Week High
$221.15$58.99
52-Week Low
$49.56$35.26
Typical Hold Time
2 Days0 Days
Enterprise Value
$37.09B$11.90B
Dividend Yield
—3.73%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Revolution Medicines Inc. Common Stock

Revolution Medicines (RVMD) trades at $188.44, down 2.84% on the day, amid a bearish technical signal. The company reported no revenue in 2025, with a net loss of $1.13 billion, and has missed earnings expectations for three consecutive quarters. However, recent positive developments include the start of a Phase 3 trial for RASONQUE in pancreatic cancer and FDA Breakthrough Therapy Designation, fueling analyst optimism.

The outlook balances high-risk, high-reward potential. Strong analyst support (91.67% buy ratings) and a $253.35 consensus price target suggest significant upside, driven by the promising oncology pipeline. Key risks include substantial cash burn, lack of current revenue, and clinical trial execution uncertainties, making the stock suitable for investors comfortable with biotech volatility.

Ternium S.A. Ternium S.A. American Depositary Shares (each representing ten shares USD1.00 par value)

Ternium (TX) trades at $58.99, up 1.81% with strong Q2 2026 earnings beating estimates by 43%. The stock shows solid fundamentals with attractive valuation metrics including P/E of 16.39 and P/S of 0.72. Recent analyst upgrades to Strong Buy highlight improving sentiment as Mexico's steel recovery drives operational momentum and the $4B Pesqueria project promises future capacity growth.

The stock offers value with 7% dividend yield projections and 14.5% upside to $65.52 fair value. Key risks include steel price volatility and trade uncertainty, but declining CapEx should boost free cash flow above 15% yield. Analyst consensus at $57.17 with 50% Buy ratings supports cautious optimism for continued recovery.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

RVMD
51% Buy49% Sell
Avg holding period · 2 Days
TX
100% Buy0% Sell
Avg holding period · 0 Days

About Revolution Medicines Inc. Common Stock

Revolution Medicines develops precision medicines for cancer. Its programs focus on targeting RAS-driven cancers and related signaling pathways.

Read more on RVMD →

About Ternium S.A. Ternium S.A. American Depositary Shares (each representing ten shares USD1.00 par value)

Ternium S.A. is a Luxembourg-headquartered steel producer operating an integrated production system, from mining through finished flat and long steel products. It runs 18 production plants and two mining operations across Argentina, Brazil, Colombia, Guatemala, Mexico, and US, serving the automotive, construction, appliance, and energy industries.

Read more on TX →